MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading

FRIDAY, March 24, 2023 (HealthDay News) — A medical device used to diagnose and treat pancreatic and bile duct disease is getting attention from the U.S. Food and Drug Administration after pieces have fallen off and remained in patients’ bodies. Previously, the FDA had expressed concern about duodenoscopes because theyContinue Reading

WEDNESDAY, March 15, 2023 (HealthDay News) — Retired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care. But Ameli, of Minneapolis, had other ideas. She and her husband sought out a pioneering medical team at Northwestern Medicine in Chicago.Continue Reading

WEDNESDAY, March 15, 2023 (HealthDay News) — Tatiana Gonzalez had just quit her job as a postal carrier, and with it the 12 miles a day she walked as she delivered people’s mail. So Gonzalez, then 39, figured that was why she suddenly became so constipated that she required laxativesContinue Reading

WEDNESDAY, March 15, 2023 (HealthDay News) — Americans are eating more food additives, according to a new study that found about 60% of foods they purchase contain coloring or flavoring agents, preservatives and sweeteners. That’s up by 10% from 2001. “Our research clearly shows that the proportion of ultra-processed foodsContinue Reading

WEDNESDAY, March 15, 2023 (HealthDay News) — Black patients are dying of pulmonary fibrosis, a devastating disease marked by progressive scarring of the lungs, at significantly younger ages than white patients. A new study probes factors contributing to earlier onset of disease, hospitalization and death in Black patients. The diseaseContinue Reading